Biogen Committees Seek Information The New York Times reports two congressional committees are seeking information about the US Food and Drug Administration's approval of Biogen's Alzheimer's disease treatment. VA Not Covering Alzheimer's Disease Drug The Wall Street Journal reports the US Department of Veterans Affairs won't cover Biogen's controversial Alzheimer's disease drug. Review of Approval Process Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug. AbbVie, Biogen, Pfizer Join With Broad Institute on Genebass Exome Variant Project Premium The biopharma companies are looking to accelerate the completion of UK Biobank Exome Sequencing Consortium data analysis to aid drug discovery. Worked Closely The New York Times reports that senior FDA officials concluded there was not enough evidence a controversial Alzheimer's disease drug was effective soon before it was approved. Dec 19, 2017 Finnish Researchers, Pharma Partners to Genotype 500K Samples as Part of New €59M Study Premium Nov 1, 2017 BC Platforms System Seeks to Unravel Mysteries of Multiple Sclerosis Premium Oct 17, 2017 Biogen Joins Collaborators in Genetics Study of Alzheimer's, Down Syndrome Oct 22, 2015 OMRF, Biogen Form Sjogren Biomarker Collaboration Oct 2, 2015 Core Informatics Adds NGS Clients to Roster; Seeks Data Analysis Partnerships Premium Oct 1, 2015 Genomics Inks Drug Screening Deal With Biogen Aug 18, 2015 Biogen, ALS Association, Columbia to Study ALS Genomics in 1,500 Patients Feb 2, 2015 Regulus Hits Milestone in Biogen Idec microRNA Biomarker Deal Jan 9, 2015 Columbia Inks $30M Genomics Research Alliance with Biogen Idec Sep 24, 2014 People in the News: Olivier Danos, Frank Witney, John Radak Premium Aug 7, 2014 Regulus Sets Bar High for HCV Program, Sees Alport Drug in Phase II by 2015 Premium Aug 5, 2014 Regulus, Biogen Ink New Agreement for Potential MS miRNA Biomarkers Mar 26, 2014 Biogen Idec Provides $5.3M for Collaboration with Whitehead Scientists Feb 19, 2014 People in the News: David Flannery, Rodney Markin, William Young, Stelios Papadopoulos Premium Nov 21, 2013 Regulus Hits Milestone in Multiple Sclerosis microRNA Biomarker Partnership Premium Oct 9, 2013 Hemophilia Genotyping Effort Funded by Biogen Idec Expanded Nationwide Premium Sep 12, 2013 Biogen Idec Exclusively Licenses Isis Antisense Tech for Neurological Diseases Premium Jun 27, 2013 Adaptive Bio, Biogen Ink Deal Aimed at Autoimmune Disease Biomarkers Feb 21, 2013 Regulus Continues to Aim for Two INDs in 2014, Expects miRNA Biomarker Data in Q3 Premium Dec 13, 2012 Isis, Biogen Idec Ink Antisense Drug-Development Partnership Premium Load More Breaking News In Brief This Week: Illumina, Personalis, Proteomedix, and More Ancient DNA Details Population Dynamics Within Andean Tiwanaku Civilization Genomic Data Spanning 2K Years Gives Glimpse of Etruscan Origins, Population Changes People in the News: New Appointments at Hologic, Akoya Biosciences, Caris Life Sciences, More At NSGC, Genetic Counselors Address Race-Based Medicine, Ways to Change New Products Posted to GenomeWeb: Becton Dickinson, Cosmos-ID, OncoDNA, More The Scan US Booster Eligibility Decision The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions. Arizona Bill Before Judge The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction. Additional Genes Wales is rolling out new genetic testing service for cancer patients, according to BBC News. Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.